Gyre Therapeutics (GYRE) Free Cash Flow (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 152.61% |
| Dec 31, 2025 | -246.08% |
| Sep 30, 2025 | 109.93% |
| Jun 30, 2025 | 846.22% |
| Mar 31, 2025 | 90.68% |
| Dec 31, 2024 | -360.70% |
| Sep 30, 2024 | 114.87% |
| Jun 30, 2024 | -361.93% |
| Mar 31, 2024 | 156.08% |
| Dec 31, 2023 | -81.53% |
| Sep 30, 2023 | 172.76% |
| Jun 30, 2023 | -76.30% |
| Mar 31, 2023 | -79.49% |
| Dec 31, 2022 | 681.26% |
| Sep 30, 2022 | 40.81% |
| Jun 30, 2022 | -2.02% |
| Mar 31, 2022 | 31.83% |
| Dec 31, 2021 | 19.99% |
| Sep 30, 2021 | -9.78% |
| Jun 30, 2021 | 17.38% |
| Mar 31, 2021 | -10.14% |
| Dec 31, 2020 | -67.49% |
| Sep 30, 2020 | 12.86% |
| Jun 30, 2020 | -215.21% |
| Mar 31, 2020 | 40.57% |
| Dec 31, 2019 | 11.13% |
| Sep 30, 2019 | 20.96% |
| Jun 30, 2019 | 23.09% |
| Mar 31, 2019 | -63.00% |
| Dec 31, 2018 | -30.82% |
| Sep 30, 2018 | 5.31% |
| Jun 30, 2018 | -39.79% |
| Mar 31, 2018 | 16.29% |
| Dec 31, 2017 | -28.57% |
| Sep 30, 2017 | -11.97% |
| Jun 30, 2017 | -2.49% |
| Mar 31, 2017 | 15.77% |
| Dec 31, 2016 | 0.62% |
| Sep 30, 2016 | -32.34% |
| Jun 30, 2016 | 19.78% |
| Mar 31, 2016 | 7.77% |
| Dec 31, 2015 | 45.58% |
| Sep 30, 2015 | -604.39% |
| Jun 30, 2015 | 54.13% |
| Mar 31, 2015 | -44.73% |
| Dec 31, 2014 | -110.60% |
| Sep 30, 2014 | 317.98% |
| Jun 30, 2014 | 39.96% |
| Mar 31, 2014 | -163.93% |
| Dec 31, 2013 | 339.17% |
| Sep 30, 2013 | 6.98% |
| Jun 30, 2013 | -11.15% |
| Mar 31, 2013 | 20.40% |
| Dec 31, 2012 | -13.38% |
| Sep 30, 2012 | 40.30% |
| Jun 30, 2012 | 30.15% |
| Mar 31, 2012 | -20.04% |
| Dec 31, 2011 | -13.88% |
| Sep 30, 2011 | 22.27% |
| Jun 30, 2011 | -3.68% |
| Mar 31, 2011 | -30.70% |
| Dec 31, 2010 | -0.81% |